Aims: Vascular smooth muscle cell (VSMC) proliferation is central to the pathophysiology of neo-intima formation. Interferon regulatory factor 3 (IRF3) inhibits the growth of cancer cells and fibroblasts. However, the role of IRF3 in vascular neo-intima formation is unknown. We evaluated the protective role of IRF3 against neo-intima formation in mice and the underlying mechanisms.
Methods And Results: IRF3 expression was down-regulated in VSMCs after carotid wire injury in vivo, and in SMCs after platelet-derived growth factor (PDGF)-BB challenge in vitro. Global knockout of IRF3 (IRF3-KO) led to accelerated neo-intima formation and proliferation of VSMCs, whereas the opposite was seen in SMC-specific IRF3 transgenic mice. Mechanistically, we identified IRF3 as a novel regulator of peroxisome proliferator-activated receptor γ (PPARγ), a negative regulator of SMC proliferation after vascular injury. Binding of IRF3 to the AB domain of PPARγ in the nucleus of SMCs facilitated PPARγ transactivation, resulting in decreased proliferation cell nuclear antigen expression and suppressed proliferation. Overexpression of wild-type, but not truncated, IRF3 with a mutated IRF association domain (IAD) retained the ability to exert anti-proliferative effect.
Conclusions: IRF3 inhibits VSMC proliferation and neo-intima formation after vascular injury through PPARγ activation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/cvr/cvu052 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A comprehensive map of proteoglycan expression and deposition in the pulmonary arterial wall in health and pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol
August 2024
Division of Physiology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Changes in the extracellular matrix of pulmonary arteries (PAs) are a key aspect of vascular remodeling in pulmonary hypertension (PH). Yet, our understanding of the alterations affecting the proteoglycan (PG) family remains limited. We sought to investigate the expression and spatial distribution of major vascular PGs in PAs from healthy individuals and various PH groups (chronic obstructive pulmonary disease: PH-COPD, pulmonary fibrosis: PH-PF, idiopathic: IPAH).
View Article and Find Full Text PDFPrevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis.
Front Cell Dev Biol
March 2022
Department of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
In renal transplantation, chronic transplant dysfunction (CTD) is associated with increased PCSK9 and dyslipidemia. PCSK9 is an enzyme that increases plasma cholesterol levels by downregulating LDLR expression. We recently showed increased PCSK9-syndecan-1 interaction in conditions of proteinuria and renal function loss.
View Article and Find Full Text PDFMetformin Suppresses the Progress of Diabetes-Accelerated Atherosclerosis by Inhibition of Vascular Smooth Muscle Cell Migration Through AMPK-Pdlim5 Pathway.
Front Cardiovasc Med
July 2021
Department of Cardiology, Translational Research Centre of Regenerative Medicine and 3D Printing of Guangzhou Medical University, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Our previous work revealed that AMP-activated protein kinase (AMPK) activation inhibits vascular smooth muscle cell migration by phosphorylating PDZ and LIM domain 5 (Pdlim5). As metformin is an AMPK activator, we used a mouse vascular smooth muscle cell (VSMC) line and a mice to investigate whether metformin could inhibit the migration of VSMCs and in a wire-injury model . It is recognized that VSMCs contribute to the major composition of atherosclerotic plaques.
View Article and Find Full Text PDFControlled autologous recellularization and inhibited degeneration of decellularized vascular implants by side-specific coating with stromal cell-derived factor 1α and fibronectin.
Biomed Mater
April 2020
Department of Cardiovascular Surgery and Research Group for Experimental Surgery, Heinrich Heine University, Medical Faculty, Duesseldorf, Germany.
Article Synopsis
- Optimized biocompatibility is essential for the longevity of cardiovascular implants, with a study focusing on the effects of specific coatings on decellularized rat aortic grafts.
- Coating the inside (luminal surface) of the grafts with stromal cell-derived factor 1α (SDF1α) led to faster cellular integration and reduced abnormal tissue growth (neo-intimal hyperplasia) compared to uncoated grafts.
- Additionally, SDF1α coating significantly decreased calcification in the grafts over an eight-week period, highlighting its potential to enhance the performance of vascular implants.
Evaluation of cellular ingrowth within porcine extracellular matrix scaffolding in congenital heart disease surgery.
Cardiovasc Pathol
May 2019
Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE, 68198-3135. Electronic address:
The search for an ideal material for cardiac tissue repair has led to utilization of porcine small intestinal submucosa extracellular matrix (CorMatrix). Here, we examine the histologic features of CorMatrix and the associated cellular growth at a variety of time intervals. Tissues with CorMatrix from ten patients (4 male, 6 female) with ages ranging from 2 weeks to 2 years, and implant duration ranging from 1 week to 2 years were included in this study.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!